Bcl-2/bcl-xL bispecific antisense treatment sensitizes breast carcinoma cells to doxorubicin, paclitaxel and cyclophosphamide (Q40687579)
scientific article published on November 2002
Language:
(P31) (Q13442814)
(P304) 157-166
(P407) (Q1860)
(P433) 2
(P478) 76
(P577) Friday, November 1, 2002
(P921) (Q18555947)
(Q18936)
(Q423762)
(P1433) (Q326085)
(P1476) "Bcl-2/bcl-xL bispecific antisense treatment sensitizes breast carcinoma cells to doxorubicin, paclitaxel and cyclophosphamide" (language: en)
(P2093) A Paula Simões-Wüst
Thomas Schürpf
Jonathan Hall
Rolf A Stahel
Uwe Zangemeister-Wittke
(P2860) (Q43548174)
(Q28469349)
(Q34325335)
(Q74179761)
(Q34341044)
(Q29618158)
(Q58289892)
(Q40942841)
(Q58024061)
(Q33962903)
(Q74081771)
(Q42483178)
(Q40970064)
(Q34645854)
(Q40747511)
(Q73190658)
(Q54052685)
(Q29547463)
(Q33876771)
(Q28145962)
(Q73687935)
(Q73863844)
(Q43761430)
(Q93896531)
other details
description scientific article published on November 2002

External Links